SEVEREULCERATIVE COLITIS ASSOCIATED WITH COOMBS POSITIVE AUTOIMMUNE HEMOLYTIC ANEMIA TREATED WITH INFLIXIMAB
Author(s) -
a Busbaih,
Albatool Abdulmajeed,
b Hodaya,
Ghufran Ali,
c Busbaih,
J. Salman
Publication year - 2021
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/13075
Subject(s) - autoimmune hemolytic anemia , ulcerative colitis , medicine , infliximab , hemolytic anemia , anemia , immunology , coombs test , colitis , gastroenterology , antibody , tumor necrosis factor alpha , disease
Autoimmune hemolytic anemia is rarely associated with ulcerative colitis, and counts only for 0.2-0.7% of adult patient.Coombs positive autoimmune hemolytic anemia which account for only 1.82% in patient with ulcerative colitis without any hemolytic evidence(1). Here we report a case of sever ulcerative colitis associated with Coombs positive autoimmune hemolytic anemia (AIHA) in response to Infliximab.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom